Abstract
We have studied the interaction of C-reactive protein (CRP)-chromatin complexes with serum. The amount of chromatin solubilized by serum is directly proportional to the amount of CRP present. Serum minus C3 did not appreciably solubilize chromatin within the time allowed in these experiments regardless of the amount of CRP present. This indicates that, in addition to CRP, complement is critical to the solubilization process. Studies using genetically C2-deficient serum and purified C2 indicate that the classical complement pathway is primarily involved in the solubilization, however, there may be minor involvement by the alternative pathway. We used an enzyme-linked immunosorbent assay to determine the amounts of CRP in plasma from eight patients with systemic lupus erythematosus; two of the eight had levels of CRP far lower than previously reported for normal individuals, and an additional sample had antibodies reactive with CRP. Together, these results suggest that one of the functions of CRP is to mediate the removal of exposed nuclear DNA by complement-dependent solubilization of chromatin. A defect in this mechanism could (a) facilitate the production of antibodies against chromatin components exposed due to tissue damage or (b) contribute to immune complexes containing the chromatin components released from damaged tissue because they are not rapidly cleared.
Full Text
The Full Text of this article is available as a PDF (833.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ANDERSON H. C., McCARTY M. Determination of C-reactive protein in the blood as a measure of the activity of the disease process in acute rheumatic fever. Am J Med. 1950 Apr;8(4):445–455. doi: 10.1016/0002-9343(50)90226-9. [DOI] [PubMed] [Google Scholar]
- Anderson J. K., Mole J. E. Large scale isolation and partial primary structure of human plasma amyloid P-component. Ann N Y Acad Sci. 1982;389:216–234. doi: 10.1111/j.1749-6632.1982.tb22139.x. [DOI] [PubMed] [Google Scholar]
- Bertouch J. V., Roberts-Thompson P. J., Feng P. H., Bradley J. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus. Ann Rheum Dis. 1983 Dec;42(6):655–658. doi: 10.1136/ard.42.6.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bornens M. Solubilization of chromatin with heparin and the isolation of nuclear membranes. Methods Cell Biol. 1977;15:163–175. doi: 10.1016/s0091-679x(08)60215-0. [DOI] [PubMed] [Google Scholar]
- Claus D. R., Osmand A. P., Gewurz H. Radioimmunoassay of human C-reactive protein and levels in normal sera. J Lab Clin Med. 1976 Jan;87(1):120–128. [PubMed] [Google Scholar]
- Cooper N. R. Activation and regulation of the first complement component. Fed Proc. 1983 Jan;42(1):134–138. [PubMed] [Google Scholar]
- Gitlin J. D., Gitlin J. I., Gitlin D. Localizing of C-reactive protein in synovium of patients with rheumatoid arthritis. Arthritis Rheum. 1977 Nov-Dec;20(8):1491–1499. doi: 10.1002/art.1780200808. [DOI] [PubMed] [Google Scholar]
- HEDLUND P. Clinical and experimental studies on C-reactive protein (acute phase protein). Acta Med Scand Suppl. 1961;361:1–71. [PubMed] [Google Scholar]
- HOKAMA Y., COLEMAN M. K., RILEY R. F. In vitro effects of C-reactive protein on phagocytosis. J Bacteriol. 1962 May;83:1017–1024. doi: 10.1128/jb.83.5.1017-1024.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KROOP I. G., SHACKMAN N. H. Level of C-reactive protein as a measure of acute myocardial infarction. Proc Soc Exp Biol Med. 1954 May;86(1):95–97. doi: 10.3181/00379727-86-21019. [DOI] [PubMed] [Google Scholar]
- Kaplan M. H., Volanakis J. E. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol. 1974 Jun;112(6):2135–2147. [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Morley J. J., Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci. 1982;389:406–418. doi: 10.1111/j.1749-6632.1982.tb22153.x. [DOI] [PubMed] [Google Scholar]
- Morrow W. J., Isenberg D. A., Parry H. F., Snaith M. L. C-reactive protein in sera from patients with systemic lupus erythematosus. J Rheumatol. 1981 Jul-Aug;8(4):599–604. [PubMed] [Google Scholar]
- Oliveira E. B., Gotschlich E. C., Liu T. Y. Comparative studies on the binding properties of human and rabbit C-reactive proteins. J Immunol. 1980 Mar;124(3):1396–1402. [PubMed] [Google Scholar]
- Pepys M. B., Baltz M. L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212. doi: 10.1016/s0065-2776(08)60379-x. [DOI] [PubMed] [Google Scholar]
- Rizzo W. B., Bustin M. Lectins as probes of chromatin structure. Binding of concanavalin A to purified rat liver chromatin. J Biol Chem. 1977 Oct 25;252(20):7062–7067. [PubMed] [Google Scholar]
- Robey F. A., Jones K. D., Tanaka T., Liu T. Y. Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein. J Biol Chem. 1984 Jun 10;259(11):7311–7316. [PubMed] [Google Scholar]
- SHETLAR M. R., BULLOCK J. A., SHETLAR C. L., PAYNE R. W. Comparison of serum C-reactive protein, glycoprotein and seromucoid in cancer, arthritis, tuberculosis and pregnancy. Proc Soc Exp Biol Med. 1955 Jan;88(1):107–109. doi: 10.3181/00379727-88-21506. [DOI] [PubMed] [Google Scholar]
- Schur P. H., Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968 Mar 7;278(10):533–538. doi: 10.1056/NEJM196803072781004. [DOI] [PubMed] [Google Scholar]
- Shapiro S. S., Thiagarajan P. Lupus anticoagulants. Prog Hemost Thromb. 1982;6:263–285. [PubMed] [Google Scholar]
- Tanaka T., Robey F. A. A new sensitive assay for the calcium-dependent binding of C-reactive protein to phosphorylcholine. J Immunol Methods. 1983 Dec 30;65(3):333–341. doi: 10.1016/0022-1759(83)90128-x. [DOI] [PubMed] [Google Scholar]
- Tenner A. J., Lesavre P. H., Cooper N. R. Purification and radiolabeling of human C1q. J Immunol. 1981 Aug;127(2):648–653. [PubMed] [Google Scholar]
- Tillett W. S., Francis T. SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS. J Exp Med. 1930 Sep 30;52(4):561–571. doi: 10.1084/jem.52.4.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Volanakis J. E. Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: evidence for covalent binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide. J Immunol. 1982 Jun;128(6):2745–2750. [PubMed] [Google Scholar]
- Voller A., Bidwell D. E., Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ. 1976;53(1):55–65. [PMC free article] [PubMed] [Google Scholar]
- Zein N., Ganuza C., Kushner I. Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus. Arthritis Rheum. 1979 Jan;22(1):7–12. doi: 10.1002/art.1780220102. [DOI] [PubMed] [Google Scholar]
- de Beer F. C., Soutar A. K., Baltz M. L., Trayner I. M., Feinstein A., Pepys M. B. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med. 1982 Jul 1;156(1):230–242. doi: 10.1084/jem.156.1.230. [DOI] [PMC free article] [PubMed] [Google Scholar]